In vivo experiments showed that compound 968 increased the infiltration of CD3+ T cells into ovarian cancer and enhanced the secretion of CXCL10 and CXCL11 by ovarian cancer cells (59). This evidence concerns the gene CXCL11 and ovarian carcinoma.